Overall, this study, for the first, proposed a microglial glycolysis/H4K12la/Pkm2 positive feedback loop that was responsible for the progression of AD, concurrently indicating a potential therapeutic target for AD (Figure 2). This evidence concerns the gene PKM and Alzheimer disease.